by Harald Quintel Start-up is not equal start-up. There is a wide range between a spin-off and a garage-company.
A rapidly changing market, interdisciplinarity, and technological breakthroughs, such as CRISPR, mean companies must rapidly adapt to ensure their success or risk being left behind. Molecular diagnostics has revolutionized the healthcare decision-making process opening up unlimited opportunities for companies in molecular testing, next-generation sequencing, and development of medical devices. Tapping into our experience ensures your success.